BIIB vs CFFI · P/E 21, rev $9.89B vs P/E 9.8, rev $77.1M
Biogen Inc (BIIB) versus C&F Financial Corporation (CFFI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
C&F Financial Corporation (CFFI) is a banks - regional company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CFFI revenue for 2026-06-30 was $77.1M. Net income was $15.3M. CFFI currently screens at market cap $210.4M and trailing P/E 9.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CFFI currently screens at market cap $210.4M and trailing P/E 9.8.
Not investment advice. Open the BIIB and CFFI stock pages for the full models.
Not investment advice.